
Vertex Pharmaceuticals remains a Buy with strong cash flow and promising drug pipeline.
Vertex Pharmaceuticals is rated as a Buy due to its durable cash flow from its cystic fibrosis (CF) franchise, which accounts for about 60% of its market value and is expected to grow steadily with patent protection. The company also has promising no...


